Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of Brian Howlett and Laurie Rostron to its board of directors.
Brian Howlett is a successful international business leader with more than 20 years’ experience of building and managing medical device and diagnostic businesses. As CEO of AIM-quoted Lombard Medical Technologies plc from 2005 to 2010, he took the company from the development stage to product sales. He also raised a total of £49 million in equity funding in challenging financial markets. From 1999 to 2005, Brian was UK Country Leader at Boston Scientific Corporation, where he was responsible for launching a number of new medical devices into the UK market. He is now utilising this experience in a portfolio of non-executive directorships and business consultancy roles.
Brian said “Accentus Medical has demonstrated considerable early stage success in commercialising its innovative surface technologies, notably the breakthrough Agluna® anti-microbial surface technology, providing a solution to the multi-$bn unmet market need of implant related infection. This success has been achieved through the vision, commitment and entrepreneurial drive of the current management team over the past several years. I am delighted to have the opportunity to join the board at this exciting stage of the company’s development. I look forward to supporting the management team on the next phase of its journey, as we seek to achieve broader commercialisation of Agluna®, and our other leading edge implant surface technologies, across the medical device market.”
Laurie Rostron is an experienced Non-Executive Director of SME’s operating in the healthcare / medical device industry, and is an advisor to a number of venture capital partnerships. He has a track record of successful investments in the healthcare industry, particularly with start-up and early stage companies commercialising leading edge technologies in high growth international markets. He was previously a partner at Alta Berkeley Associates, focused on healthcare investments.
Laurie said “Having worked as business advisor to Accentus Medical for a number of years, I welcome the opportunity to join the company’s board of directors. Under the current management team, the company has achieved a great deal, delivering consistent year-on-year growth in revenue streams with an increasing portfolio of international medical device customers. This team now has an ambitious growth plan to expand its customer base, and to develop its core Acusure® and Agluna® technology platforms so as to unlock further global market potential for these value-enhancing products.”
Philip Agg, Chief Executive Officer said: “I am delighted to welcome Brian and Laurie to the board of directors. I and the wider management team look forward to benefitting from their wisdom, insight and experience of working with high growth companies within the global medical device industry.”
-ends-
For further information, please contact:
Philip Agg, CEO
T: +44 (0)1235 434328
Email: enquiries@accentus-medical.com